Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen and Zymark to Combine Nucleic Acid Handling Technologies

NEW YORK, May 3 – Zymark and Qiagen have agreed to develop and launch ultra high-throughput nucleic acid handling automation systems that will combine the two companies’ products, the companies said Thursday.

Zymark of Hopkinton, Mass. manufactures laboratory automation and robotic systems for life sciences customers. 

The joint effort will combine Qiagen’s BioRobot platforms with Zymark’s RapidPlate 96/384 Microplate Pipetting Workstation, Staccato workstations, and Twister Universal Microplate Handler. 

"The alliance with Zymark expands the reach of our nucleic acid handling, separation, and purification technologies into the highest throughput environments in genomics by leveraging on Zymark's remarkable laboratory integration technologies," Qiagen CEO Metin Colpan said in a statement.

Qiagen, a Netherlands holding company, supplies products for the separation, purification, and handling of nucleic acids. Over the last year, the company has signed on to joint ventures and licensing agreements with Agilent Technologies, Japan’s Daiichi Pharmaceutical subsidiary of Daiichi Pure Chemicals, the University of Washington School of Pharmacy, Zeptosens AG of Germany, Becton, Dickinson, and Luminex.

In April, Qiagen acquired Japanese nucleic acid maker Sawady. The company has also recently acquired Operon Technologies and Rapigene, now renamed Qiagen Genomics


The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.